Search results: Sage Journals

Open accessReview articleFirst published 2021

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease

Erin M. Wilfong, Rohit Aggarwal

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2020

Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis

Yuya Aono, Yutaro Nakamura, Masato Kono [...]

Therapeutic Advances in Respiratory Disease

Open accessReview articleFirst published 2022

The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease

Minrui Liang, Eric L. Matteson, Andy Abril [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2019

Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study

Keiji Oishi, Tsunahiko Hirano, Yoriyuki Murata [...]

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2024

Real-world antifibrotic treatment patterns in patients with idiopathic pulmonary fibrosis: retrospective analyses of two large healthcare administrative databases in the United States

Ying Qiu, Julia Zhu, Pooja Chopra [...]

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2025

Effectiveness of antifibrotics on health-related quality of life in patients with interstitial lung disease: a systematic review and meta-analysis

Jihye Lee, Shinhee Park, Hee-Young Yoon

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2025

Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study

Christian Cardillo, Gerard J. Criner, Shameek Gayen

Therapeutic Advances in Respiratory Disease

Free accessResearch articleFirst published August, 2016

Toward an antifibrotic therapy for inflammatory bowel disease

Florian Rieder

United European Gastroenterology Journal

Open accessResearch articleFirst published 2024

Impact of antifibrotic therapy on disease progression,all-cause mortality,and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies

De-yu Li, Xin Liu, Jing-yi Huang [...]

Therapeutic Advances in Respiratory Disease

Available accessResearch articleFirst published December, 2023

Biomimetic Cardiac Fibrotic Model for Antifibrotic Drug Screening

Haiyan Li, Yifan Zhu, Zhe Chen [...]

Tissue Engineering Part C: Methods

Open accessReview articleFirst published 2021

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease

Erin M. Wilfong, Rohit Aggarwal

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2020

Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis

Yuya Aono, Yutaro Nakamura, Masato Kono [...]

Therapeutic Advances in Respiratory Disease

Open accessReview articleFirst published 2022

The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease

Minrui Liang, Eric L. Matteson, Andy Abril [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2019

Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study

Keiji Oishi, Tsunahiko Hirano, Yoriyuki Murata [...]

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2024

Real-world antifibrotic treatment patterns in patients with idiopathic pulmonary fibrosis: retrospective analyses of two large healthcare administrative databases in the United States

Ying Qiu, Julia Zhu, Pooja Chopra [...]

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2025

Effectiveness of antifibrotics on health-related quality of life in patients with interstitial lung disease: a systematic review and meta-analysis

Jihye Lee, Shinhee Park, Hee-Young Yoon

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2025

Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study

Christian Cardillo, Gerard J. Criner, Shameek Gayen

Therapeutic Advances in Respiratory Disease

Free accessResearch articleFirst published August, 2016

Toward an antifibrotic therapy for inflammatory bowel disease

Florian Rieder

United European Gastroenterology Journal

Open accessResearch articleFirst published 2024

Impact of antifibrotic therapy on disease progression,all-cause mortality,and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies

De-yu Li, Xin Liu, Jing-yi Huang [...]

Therapeutic Advances in Respiratory Disease

Available accessResearch articleFirst published December, 2023

Biomimetic Cardiac Fibrotic Model for Antifibrotic Drug Screening

Haiyan Li, Yifan Zhu, Zhe Chen [...]

Tissue Engineering Part C: Methods